Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans

Journal of Clinical Investigation

Volumn 112, Issue 7, 2003, Pages 1080-1094

  Luberto, Chiara ^a   Martinez Mariño, Beatriz ^b   Taraskiewicz, Daniel ^a   Bolaños, Benjamin ^b   Chitano, Pasquale ^c   Toffaletti, Dena L ^c   Cox, Gary M ^c   Perfect, John R ^c   Hannun, Yusuf A ^a   Balish, Edward ^a   Del Poeta, Maurizio ^a,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APP1 PROTEIN; COMPLEMENT COMPONENT C5; COMPLEMENTARY DNA; FUNGAL PROTEIN; RECOMBINANT PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL VIRULENCE; GENE DISRUPTION; HOST RESISTANCE; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BRAIN; GENETICS; IMMUNOLOGY; LUNG; MALE; NATURAL KILLER CELL; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VIRULENCE;

ANIMALS; BRAIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; KILLER CELLS, NATURAL; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; PHAGOCYTOSIS; T-LYMPHOCYTES; VIRULENCE;

EID: 85047694795     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18309     Document Type: Article

References (57)

1. Casadevall, A., and Perfect, J.R. 1998. Cryptococcus neoformans. American Society for Microbiology. Washington, DC, USA. 407-456.
2. Diamond, R.D., May, J.E., Kane, M.A., Frank, M.M., and Bennett, J.E. 1974. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J. Immunol. 112:2260-2270.
3. Levitz, S.M. 1994. Macrophage-cryptococcus interactions. In Macrophage-pathogen interactions. Marcel Dekker Inc. New York, New York, USA. 533-543.
4. Murphy, J.W., Zhou, A., and Wong, S.C. 1997. Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect. Immun. 65:4564-4571.
5. Kawakami, K., et al. 2000. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Microbiol. Immunol. 44:1043-1050.
6. Murphy, J.W., Hidore, M.R., and Wong, S.C. 1993. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J. Clin. Invest. 91:1553-1566.
7. Cox, G.M., et al. 2001. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol. Microbiol. 39:166-175.
8. Noverr, M.C., Toews, G.B., and Huffnagle, G.B. 2002. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect. Immun. 70:400-402.
9. Luberto, C., et al. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 15:201-212.
10. Diamond, R.D., and Bennett, J.E. 1973. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J. Infect. Dis. 127:694-697.
11. Feldmesser, M., Tucker, S., and Casadevall, A. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278.
12. Reardon, C.C., Kim, S.J., Wagner, R.P., and Kornfeld, H. 1996. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro. Am. J. Respir. Cell Mol. Biol. 15:711-715.
13. Diamond, R.D., Root, R.K., and Bennett, J.E. 1972. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J. Infect. Dis. 125:367-376.
14. Diamond, R.D., and Bennett, J.E. 1973. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect. Immun. 7:231-236.
15. Huffnagle, G.B., Boyd, M.B., Street, N.E., and Lipscomb, M.F. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
16. Chang, W.L., van der Heyde, H.C., and Klein, B.S. 1998. Flow cytometric quantitation of yeast: a novel technique for use in animal model work and in vitro immunologic assays. J. Immunol. Methods. 211:51-63.
17. Levitz, S.M., et al. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
18. Tucker, S.C., and Casadevall, A. 2002. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. U. S. A. 99:3165-3170.
19. Wang, B., et al. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc. Natl. Acad. Sci. U. S. A. 91:9402-9406.
20. Hu, B., Sonstein, J., Christensen, P.J., Punturieri, A., and Curtis, J.L. 2000. Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages. J. Immunol. 165:2124-2133.
21. Toffaletti, D.L., Rude, T.H., Johnston, S.A., Durack, D.T., and Perfect, J.R. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.
22. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 9.31-9.58.
23. Cox, G.M., Toffaletti, D.L., and Perfect, J.R. 1996. Dominant selection system for use in Cryptococcus neoformans. J. Med. Vet. Mycol. 34:385-391.
24. Wang, B., Simpson, S.J., Hollander, G.A., and Terhorst, C. 1997. Development and function of T lymphocytes and natural killer cells after bone marrow transplantation of severely immunodeficient mice. Immunol. Rev. 157:53-60.
25. Rhodes, J.C., Wicker, L.S., and Urba, W.J. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 29:494-499.
26. Su, Z., and Stevenson, M.M. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168:1348-1355.
27. Sam, H., and Stevenson, M.M. 1999. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria. Clin. Exp. Immunol. 117:343-349.
28. Karp, C.L., et al. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1:221-226.
29. Martinez-Mariño, B., Del Poeta, M., Perfect, J.R., and Bolaños, B. 1999. Cloning and expression of a Cryptococcus neoformans gene encoding a protein associated with inhibition of phagocytosis. In Abstracts of the 99th general meeting of the American Society for Microbiology. May 30-June 3. Chicago, Illinois, USA. 76.
30. Falquet, L., et al. 2002. The PROSITE database, its status in 2002. Nucleic Acids Res. 30:235-238.
31. Ratcliffe, L.T., Lukey, P.T., MacKenzie, C.R., and Ress, S.R. 1994. Reduced NK activity correlates with active disease in HIV-patients with multidrug-resistant pulmonary tuberculosis. Clin. Exp. Immunol. 97:373-379.
32. + T-lymphocytopenia - four patients with opportunistic infections and no evidence of HIV infection. N. Engl. J. Med. 328:393-398.
33. + patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161:6433-6438.
34. Lazcano, O., et al. 1993. Combined histochemical stains in the differential diagnosis of Cryptococcus neoformans. Mod. Pathol. 6:80-84.
35. Salgado, D.C., Lebrón de Jesús, J.M., and Bolaños, B. 1994. Purification and characterization of a cytoplasmic immunosuppressive component from Cryptococcus neoformans by preparative electrophoretic techniques. In Abstracts of the 94th general meeting of the American Society for Microbiology. March 23-27. Las Vegas, Nevada, USA. 77.
36. Luberto, C., Heung, L.J., Hannun, Y.A., and Del Poeta, M. 2002. Inositol phosphoryl ceramide synthase 1 (IPC1) plays a major role in the regulation of sphingolipid levels. In Abstracts of the 5th International Conference on Cryptococcus and Cryptococcosis. March 3-8. Adelaide, Australia. 180.
37. Welsh, N. 1996. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J. Biol. Chem. 271:8307-8312.
38. Mansour, M.K., and Levitz, S.M. 2002. Interactions of fungi with phagocytes. Curr. Opin. Microbiol. 5:359-365.
39. He, W., Casadevall, A., Lee, S.C., and Goldman, D.L. 2003. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infect. Immun. 71:930-936.
40. Taborda, C.P., and Casadevall, A. 2002. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity. 16:791-802.
41. Vecchiarelli, A., Pietrella, D., Bistoni, F., Kozel, T.R., and Casadevall, A. 2002. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rβ2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells. Immunology. 106:267-272.
42. Forsyth, C.B., Plow, E.F., and Zhang, L. 1998. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J. Immunol. 161:6198-6205.
43. Newman, S.L., Chaturvedi, S., and Klein, B.S. 1995. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J. Immunol. 154:753-761.
44. Dong, Z.M., and Murphy, J.W. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65:557-563.
45. Cross, C.E., Collins, H.L., and Bancroft, G.J. 1997. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology. 91:289-296.
46. Agramonte-Hevia, J., Gonzalez-Arenas, A., Barrera, D., and Velasco-Velazquez, M. 2002. Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3. FEMS Immunol. Med. Microbiol. 34:255-266.
47. Kawakami, K., et al. 2000. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J. Immunol. 165:941-947.
48. Salkowski, C.A., and Balish, E. 1991. Role of natural killer cells in resistance to systemic cryptococcosis. J. Leukoc. Biol. 50:151-159.
49. Hidore, M.R., Nabavi, N., Sonleitner, F., and Murphy, J.W. 1991. Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect. Immun. 59:1747-1754.
50. Bobek, L.A., and Situ, H. 2003. MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action. Antimicrob. Agents Chemother. 47:643-652.
51. Satyanarayana, J., et al. 2000. Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7. J. Pept. Res. 56:275-282.
52. Situ, H., and Bobek, L.A. 2000. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Antimicrob. Agents Chemother. 44:1485-1493.
53. Gururaja, T.L., et al. 1999. Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1. Biochim. Biophys. Acta. 1431:107-119.
54. Fahy, J.V. 2002. Goblet cell and mucin gene abnormalities in asthma. Chest. 122:320S-326S.
55. Chretien, F., et al. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 186:522-530.
56. Luberto, C., et al. 2002. Role of inositol phosphoryl ceramide synthase 1 (IPC1) in the regulation of phagocytosis. In Abstracts of the 5th International Conference on Cryptococcus and Cryptococcosis. March 3-8. Adelaide, Australia. 181.
57. Heung, L.J., Plowden, A., Luberto, C., and Del Poeta, M. 2002. Role of protein kinase C (PKC1) gene from Cryptococcus neoformans in the regulation of melanin production. In Abstracts of the 5th International Conference on Cryptococcus and Cryptococcosis. March 3-8. Adelaide, Australia. 171.